• Western blot analysis of 1, 293T 2, hela cells using primary antibody diluted at 1:1000 (4°C overnight). Secondary antibody:Goat Anti-rabbit IgG IRDye 800 ( diluted at 1:5000, 25°C, 1 hour)

Anti-GCK/GLK antibody (221-270 aa) (STJ99334)

SKU:
STJ99334

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Mitogen-activated protein kinase kinase kinase kinase 2 and Mitogen-activated protein kinase kinase kinase kinase 3 (221-270 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
ELISA 1:10000-20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MAP4K3
MAP4K2
Gene ID: 8491
5871
Uniprot ID: M4K3_HUMAN
M4K2_HUMAN
Immunogen Region: 221-270 aa
Specificity: GCK/GLK Polyclonal Antibody detects endogenous levels of GCK/GLK
Immunogen: Synthesized peptide derived from the human GCK/GLK at the amino acid range 221-270
Post Translational Modifications Polyubiquitinated through 'Lys-48'-polyubiquitin chains, allowing proteasomal turnover. Ubiquitination requires the kinase activity of MAP4K2/GCK. Autophosphorylated in response to tumor necrosis factor (TNF), endotoxins or proinflammatory stimuli. Autophosphorylation leads to activation.
Function Serine/threonine-protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Acts as a MAPK kinase kinase kinase (MAP4K) and is an upstream activator of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway and to a lesser extent of the p38 MAPKs signaling pathway. Required for the efficient activation of JNKs by TRAF6-dependent stimuli, including pathogen-associated molecular patterns (PAMPs) such as polyinosine-polycytidine (poly(IC)), lipopolysaccharides (LPS), lipid A, peptidoglycan (PGN), or bacterial flagellin. To a lesser degree, IL-1 and engagement of CD40 also stimulate MAP4K2-mediated JNKs activation. The requirement for MAP4K2/GCK is most pronounced for LPS signaling, and extends to LPS stimulation of c-Jun phosphorylation and induction of IL-8. Enhances MAP3K1 oligomerization, which may relieve N-terminal mediated MAP3K1 autoinhibition and lead to activation following autophosphorylation. Mediates also the SAP/JNK signaling pathway and the p38 MAPKs signaling pathway through activation of the MAP3Ks MAP3K10/MLK2 and MAP3K11/MLK3. May play a role in the regulation of vesicle targeting or fusion. regulation of vesicle targeting or fusion.
Protein Name Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2
B Lymphocyte Serine/Threonine-Protein Kinase
Germinal Center Kinase
Gc Kinase
Mapk/Erk Kinase Kinase Kinase 2
Mek Kinase Kinase 2
Mekkk 2
Rab8-Interacting Protein
Cellular Localisation Cytoplasm
Basolateral Cell Membrane
Peripheral Membrane Protein
Golgi Apparatus Membrane
Alternative Antibody Names Anti-Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 antibody
Anti-B Lymphocyte Serine/Threonine-Protein Kinase antibody
Anti-Germinal Center Kinase antibody
Anti-Gc Kinase antibody
Anti-Mapk/Erk Kinase Kinase Kinase 2 antibody
Anti-Mek Kinase Kinase 2 antibody
Anti-Mekkk 2 antibody
Anti-Rab8-Interacting Protein antibody
Anti-MAP4K2 antibody
Anti-GCK antibody
Anti-RAB8IP antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance